Roles of Prophylactic Subcutaneous Drain in Preventing Surgical Site Infection in Surgical Wound After Abdominal Surgery - Trial NCT06063629
Access comprehensive clinical trial information for NCT06063629 through Pure Global AI's free database. This phase not specified trial is sponsored by Queen Savang Vadhana Memorial Hospital, Thailand and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 180 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Queen Savang Vadhana Memorial Hospital, Thailand
Timeline & Enrollment
N/A
Dec 01, 2023
Feb 01, 2025
Primary Outcome
Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI),Rate of Surgical Site Infection (SSI)
Summary
Surgical site infections (SSI) pose a common challenge in the field of surgery. Current
 evidence and literature do not provide clear consensus whether the use of subcutaneous
 drainage will help reduce the incidence of SSI in patients who underwent abdominal surgery,
 especially in wounds that are categorized as contaminated (class 3) or dirty/infected (class
 4).
 
 The objective of this clinical study is to compare the rate of surgical site infection in
 contaminated and dirty/infected surgical wounds among patients whose wounds are inserted with
 subcutaneous drainage and patients who are not inserted with subcutaneous drainage.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06063629
Non-Device Trial